Filing Details
- Accession Number:
- 0001827722-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-19 18:30:59
- Reporting Period:
- 2023-12-15
- Accepted Time:
- 2023-12-19 18:30:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819790 | Tarsus Pharmaceuticals Inc. | TARS | Biological Products, (No Disgnostic Substances) (2836) | 814717861 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1827722 | D. Andrew Goldberg | C/O Tarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-15 | 1,000 | $18.96 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
